Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Neurosurgery, Oslo University Hospital, N-0027, Oslo, Norway.
Neurosurg Rev. 2019 Dec;42(4):961-972. doi: 10.1007/s10143-018-1005-6. Epub 2018 Jul 5.
To compare outcomes after surgery for skull base meningiomas (SBMs) with non-skull base meningiomas (NSBMs) in the elderly. Overall, 128 consecutive patients ≥ 70 years of age with intracranial SBMs operated between 1990 and 2010 were compared to 193 consecutive patients ≥ 70 years of age with NSBMs operated within the same time period. Median age at surgery was 75.0 years (mean 75.7, range 70.0-92.4). Follow-up was complete with median 4.7 years (mean 5.5, range 0-19). The female-to-male ratio was 2.8 for SBMs and 1.3 for NSBMs (p < 0.005). The groups had similar preoperative KPS (median 80, range 20-100), but SBMs presented significantly more frequently with raised ICP (RR = 2.2, p < 0.005) and less frequently with seizures (RR = 0.6, p < 0.05). WHO I was significantly more frequent in SBMs (p < 0.005). Gross-total resection (GTR) was less frequent in SBMs (63 vs 82%) (RR = 2.1, p < 0.0001). SBMs were similar to NSBMs with respect to neurological outcome at 6-12 months, reoperations for hematomas, postoperative infections, and 30-day mortality. Retreatment rates and time to retreatments were also similar. There were no differences between the two groups with respect to risk of retreatment and overall survival (OS) at 5, 10, 15, and 20 years. In elderly patients with SBMs selected to surgical treatment, the risks of surgery, risk of retreatment, and OS were similar to NBSMs. Therefore, surgery for SBMs may be considered as safe as NSBMs in the elderly population.
比较老年患者颅底脑膜瘤(SBMs)与非颅底脑膜瘤(NSBMs)手术后的结果。总体而言,比较了 1990 年至 2010 年间手术治疗的 128 例年龄≥70 岁的颅内 SBM 患者与同期手术治疗的 193 例年龄≥70 岁的 NSBM 患者。手术时的中位年龄为 75.0 岁(平均 75.7 岁,范围 70.0-92.4)。中位随访时间为 4.7 年(平均 5.5 年,范围 0-19 年)。SBMs 的男女比例为 2.8,NSBMs 为 1.3(p<0.005)。两组患者术前 KPS(中位 80,范围 20-100)相似,但 SBMs 患者颅内压升高(RR=2.2,p<0.005)的发生率显著更高,癫痫发作(RR=0.6,p<0.05)的发生率显著更低。SBMs 中 WHO I 级更为常见(p<0.005)。SBMs 中全切除(GTR)的比例较低(63% vs 82%)(RR=2.1,p<0.0001)。SBMs 与 NSBMs 相比,6-12 个月时的神经功能预后、血肿再次手术、术后感染和 30 天死亡率相似。再治疗率和再治疗时间也相似。两组之间的再治疗风险和总生存(OS)无差异。在选择手术治疗的老年 SBMs 患者中,手术风险、再治疗风险和 OS 与 NSBMs 相似。因此,对于老年人群,SBMs 的手术治疗可以被认为与 NSBMs 一样安全。